TipRanks
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
2616
CStone Pharmaceuticals
RESEARCH TOOLSreports
Want to see HK:2616 full AI Analyst Report?

CStone Pharmaceuticals (2616) Revenue

5 Followers
StatisticsMarket CapRevenue

CStone Pharmaceuticals Revenue

CStone Pharmaceuticals had a revenue of 202.27M in the quarter ending Jun 30, 2026, with -8.12%. This bring the company's revenue in the last twelve months to 422.40M, Decreased 72.51%. In the fiscal year ending Dec 31, 2025, CStone Pharmaceuticals had annual revenue of 269.58M with -33.80% growth.
Revenue (ttm)
422.40M
Revenue Growth
116.67%
P/S Ratio
28.84
Revenue/Employee
HK$1,833,898
Employees
147
Market Cap
HK$7.77B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
269.58M-137.62M-33.80%
Dec 31, 2024
407.20M-56.64M-12.21%
Dec 31, 2023
463.84M-17.52M-3.64%
Dec 31, 2022
481.36M237.65M+97.51%
Dec 31, 2021
243.72M-795.11M-76.54%
Dec 31, 2020
1.04B―+∞%
Dec 31, 2019
―-12.55M-100.00%
Dec 31, 2018
12.55M2.25M+21.84%
Dec 31, 2017
10.30M――